KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Total Liabilities (2016 - 2025)

LifeMD (LFMD) has disclosed Total Liabilities for 14 consecutive years, with $47.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 43.51% year-over-year to $47.3 million, compared with a TTM value of $47.3 million through Dec 2025, down 43.51%, and an annual FY2025 reading of $47.3 million, down 43.51% over the prior year.
  • Total Liabilities was $47.3 million for Q4 2025 at LifeMD, down from $62.6 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $83.7 million in Q4 2024 and bottomed at $15.8 million in Q1 2021.
  • Average Total Liabilities over 5 years is $48.2 million, with a median of $46.5 million recorded in 2023.
  • The sharpest move saw Total Liabilities soared 256.02% in 2021, then crashed 43.51% in 2025.
  • Year by year, Total Liabilities stood at $24.1 million in 2021, then soared by 36.79% to $33.0 million in 2022, then surged by 60.49% to $52.9 million in 2023, then skyrocketed by 58.09% to $83.7 million in 2024, then tumbled by 43.51% to $47.3 million in 2025.
  • Business Quant data shows Total Liabilities for LFMD at $47.3 million in Q4 2025, $62.6 million in Q3 2025, and $73.2 million in Q2 2025.